These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27084038)

  • 21. Interferon and Hepatitis B: Current and Future Perspectives.
    Ye J; Chen J
    Front Immunol; 2021; 12():733364. PubMed ID: 34557195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms.
    Thomas E; Baumert TF
    Semin Liver Dis; 2019 Jul; 39(3):301-314. PubMed ID: 31266064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
    Lan P; Zhang C; Han Q; Zhang J; Tian Z
    Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.
    Novotny LA; Evans JG; Su L; Guo H; Meissner EG
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.
    Ma Z; Zhang E; Gao S; Xiong Y; Lu M
    Front Immunol; 2019; 10():2308. PubMed ID: 31608073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathogenesis of chronic hepatitis B.
    Balmasova IP; Yushchuk ND; Mynbaev OA; Alla NR; Malova ES; Shi Z; Gao CL
    World J Gastroenterol; 2014 Oct; 20(39):14156-71. PubMed ID: 25339804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.
    Faure-Dupuy S; Lucifora J; Durantel D
    Viruses; 2017 Apr; 9(5):. PubMed ID: 28452930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
    Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
    J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.
    Pei RJ; Chen XW; Lu MJ
    World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection.
    Golsaz-Shirazi F; Amiri MM; Shokri F
    Rev Med Virol; 2018 Nov; 28(6):e2007. PubMed ID: 30175481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
    Chang KM; Liu M
    Curr Opin Pharmacol; 2016 Oct; 30():93-105. PubMed ID: 27570126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
    Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
    J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Tim-3 in hepatitis B virus infection: An overview.
    Liu Y; Gao LF; Liang XH; Ma CH
    World J Gastroenterol; 2016 Feb; 22(7):2294-303. PubMed ID: 26900291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathology of hepatitis B virus infection.
    Tsai HT; Tsai TH; Lu TM; Yang CC
    Int Rev Immunol; 2008; 27(6):427-46. PubMed ID: 19065350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.
    Zheng P; Dou Y; Wang Q
    Front Cell Infect Microbiol; 2023; 13():1206720. PubMed ID: 37424786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate Immunity, Inflammation, and Intervention in HBV Infection.
    Yang G; Wan P; Zhang Y; Tan Q; Qudus MS; Yue Z; Luo W; Zhang W; Ouyang J; Li Y; Wu J
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.